Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.

doi:10.1158/1078-0432.CCR-23-3018

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Apr 2024

Lim-Fat Mary Jane, Iorgulescu J Bryan, Rahman Rifaquat, Bhave Varun, Muzikansky Alona, Woodward Eleanor, Whorral Sydney, Allen Marie, Touat Mehdi, Li Xiaomei, Xy Gongwen, Patel Jay, Gerstner Elizabeth R, Kalpathy-Cramer Jayashree, Youssef Gilbert, Chukwueke Ugonma, McFaline-Figueroa J Ricardo, Nayak Lakshmi, Lee Eudocia Q, Reardon David A, Beroukhim Rameen, Huang Raymond Y, Bi Wenya Linda, Ligon Keith L, Wen Patrick Y

Abstract excerpt

PURPOSE: Adverse clinical events cause significant morbidity in patients with GBM (GBM). We examined whether genomic alterations were associated with AE (AE) in patients with GBM. EXPERIMENTAL DESIGN: We identified adults with histologically confirmed IDH-wild-type GBM with targeted next-generation sequencing (OncoPanel) at Dana Farber Cancer Institute from 2013 to 2019. Seizure at presentation, lymphopenia,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to DNA Helicases

Share to Genomics

Share to Glioblastoma

Share to Nuclear Proteins

Share to Seizures

Share to Transcription Factors

Source

Open in PubMed

Identifiers

PMID: 38252427
DOI: 10.1158/1078-0432.CCR-23-3018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.PMID 38252427Read ↗

Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study.Semantic proximity Read ↗

Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.Semantic proximity Read ↗

Identification of Candidate Genes Associated With Prognosis in GlioblastomaSemantic proximity Read ↗

Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.Semantic proximity Read ↗

Integrated genomic analysis of survival outliers in glioblastomaSemantic proximity Read ↗

Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.Semantic proximity Read ↗

Molecular characterization of high-grade glioma-associated seizuresSemantic proximity Read ↗

An integrated genomic analysis of human glioblastoma multiforme.Semantic proximity Read ↗

Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.Semantic proximity Read ↗

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.Semantic proximity Read ↗

The genes significantly associated with an improved prognosis and long-term survival of glioblastomaSemantic proximity Read ↗

Integrating genomic, transcriptomic and epigenetic data to identify phenotypically impactful driver pathways in glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.